This therapy can justifiably be called universal, as it focused on molecules that are contained in 90% of all tumors. Injection of this drug allows the human immune system to defend against various cancers, including breast cancer and prostate cancer - the main killer of women and men.
Preliminary results of the first phase of clinical trials have shown that vaccine against cancer bring forth the desired immune response and reduce disease. Now its creators hope to conduct more extensive research on patients that prove the effectiveness of a vaccine to combat different types of cancer.
This joint development of researchers from the pharmaceutical company Vaxil Biotheraputics and the University of Tel Aviv. The creators cancer vaccine They find that it can help to combat small tumors. That is, to treat cancer at an early stage, when it has not had time to recurrence or spread to other organs.
Normally, cancer cells escape the attack of our immune system, because it is not recognized as a threat. The immune system effectively has a foreign cells such as bacteria, and tumors consist of our own cells become at some point malignant. However, researchers found that the MUC1 molecule, contained in the set on the surface of cancer cells can be used for accurate guidance of our immune system to the tumor.
Industry News
Go back to the main page
No comments:
Post a Comment